Physician profile
Emily Killian
NPI 1598363475
$1,105.43
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $73.09 · 2022: $185 · 2023: $653 · 2024: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $847.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $348.06 | 2022-2024 | Breztri, Airsupra, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $150.10 | 2022-2023 | Stiolto Respimat, Spiriva Respimat, Ofev |
| Glaxosmithkline, LLC. | $146.19 | 2023-2024 | Trelegy Ellipta, Nucala |
| Amgen INC. | $73.09 | 2021 | |
| Grifols USA, LLC | $61.90 | 2022-2023 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $59.71 | 2022-2023 | Yupelri |
| Inogen, INC. | $52.10 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Harmony Biosciences LLC | $44.64 | 2023 | Wakix |
| Genzyme Corporation | $36.44 | 2023-2024 | |
| Genentech USA, INC. | $36.04 | 2023-2024 | Xolair |
| United Therapeutics Corporation | $25.26 | 2024 | Tyvaso |
| Zoll Respicardia, INC. | $21.31 | 2024 | Remede System |
| Merck Sharp & Dohme LLC | $20.97 | 2023 | |
| Electromed, INC. | $16.45 | 2023 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $13.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Killian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.